Some investors asked Daqing Huake, how is the disposal of the pharmaceutical branch's machinery and equipment assets currently progressing? Is there already an intended transferee? If the public listing is still unable to be completed, is the company considering internal transfers, agreement transfers, or other means of disposal? On November 10, the company replied that at present, the pharmaceutical branch's machinery and equipment assets have not yet found an intended transferee, and the company will wait until the time is ripe to re-carry out the approval procedures and information disclosure of the pharmaceutical branch's asset transactions.

Some investors asked Daqing Huake, how is the disposal of the pharmaceutical branch's machinery and equipment assets currently progressing? Is there already an intended transferee? If the public listing is still unable to be completed, is the company considering internal transfers, agreement transfers, or other means of disposal? On November 10, the company replied that at present, the pharmaceutical branch's machinery and equipment assets have not yet found an intended transferee, and the company will wait until the time is ripe to re-carry out the approval procedures and information disclosure of the pharmaceutical branch's asset transactions.